Doximity Hold Rating: Balancing Strong Market Position With Political and Competitive Uncertainties
Doximity Initiated at Neutral by Mizuho
Mizuho Initiates Coverage On Doximity With Neutral Rating, Announces Price Target of $55
Jefferies Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $64
Jefferies Maintains Doximity(DOCS.US) With Buy Rating, Raises Target Price to $64
Doximity Analyst Ratings
Doximity Initiated at Neutral by Goldman Sachs
Goldman Sachs Initiates Doximity(DOCS.US) With Hold Rating, Announces Target Price $58
Balanced Risk/Reward Scenario Leads to Neutral Stance on Doximity
Baird Maintains Doximity(DOCS.US) With Buy Rating, Raises Target Price to $61
Doximity Analyst Ratings
Truist Financial Maintains Doximity(DOCS.US) With Hold Rating
Doximity (DOCS) Gets a Hold From Truist Financial
Morgan Stanley Upgrades Doximity(DOCS.US) to Hold Rating, Raises Target Price to $53
CCORF Downgrades Doximity(DOCS.US) to Hold Rating, Raises Target Price to $60
Doximity Is Maintained at Overweight by Barclays
Doximity Analyst Ratings
Barclays Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $75
Doximity (DOCS) Receives a Buy From Barclays
Raymond James Reiterates Outperform on Doximity, Raises Price Target to $65